CVE-2023-26969: Atrocore Atropim

High severity, CVSS 7.5. EPSS: 1.1% chance of exploitation in the next 30 days.

Atropim 1.5.26 is vulnerable to Directory Traversal.

Affected products

• Atrocore Atropim: version 1.5.26 only

Published 2023-04-14. Last modified 2026-06-17.